Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia

Abstract

Therapeutic effects of mesenchymal stem cell (MSC) infusion have been revealed in various human disorders, but impacts of diseased micro-environments are only beginning to be noticed. Donor diabetic hyperglycemia is reported to impair therapeutic efficacy of stem cells. However, whether recipient diabetic condition also affects MSC-mediated therapy is unknown. We and others have previously shown that MSC infusion could cure osteopenia, particularly in ovariectomized (OVX) mice. Here, we discovered impaired MSC therapeutic effects on osteopenia in recipient type 1 diabetes (T1D). Through intensive glycemic control by daily insulin treatments, therapeutic effects of MSCs on osteopenia were maintained. Interestingly, by only transiently restoration of recipient euglycemia using single insulin injection, MSC infusion could also rescue T1D-induced osteopenia. Conversely, under recipient hyperglycemia induced by glucose injection in OVX mice, MSC-mediated therapeutic effects on osteopenia were diminished. Mechanistically, recipient hyperglycemic micro-environments reduce anti-inflammatory capacity of MSCs in osteoporotic therapy through suppressing MSC interaction with T cells via the Adenosine monophosphate-activated protein kinase (AMPK) pathway. We further revealed in diabetic micro-environments, double infusion of MSCs ameliorated osteopenia by anti-inflammation, attributed to the first transplanted MSCs which normalized the recipient glucose homeostasis. Collectively, our findings uncover a previously unrecognized role of recipient glycemic conditions controlling MSC-mediated therapy, and unravel that fulfillment of potent therapeutic effects of MSCs requires tight control of recipient micro-environments.

Anti‐aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application

“…Western blot was performed for mice and rat wound bed samples as previously described (Sui et al ., ). Tissue lysates were prepared using the Cell Lysis Buffer (Beyotime, Shanghai, China).…”

Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice

“…Isolation and culture of murine BMMSCs were according to our previous protocol 41 , 42 . Briefly, bone marrow cells were sampled from the hindlimbs of mice and were seeded for incubation overnight at 37 ℃ in a humidified atmosphere of 5% CO 2 .…”

NDRG2 suppression as a molecular hallmark of photoreceptor-specific cell death in the mouse retina

“…1c, d ). Furthermore, the loss of 661 W cell viability could be attributed to provoked cell death by H 2 O 2 and MNU, as shown by increased positively stained proportion of propidium iodide (PI) for dead cells 25 , 26 (Supplementary Fig. 1A) .…”

“…Briefly, after treatment by H 2 O 2 or MNU, or transfected with lentiviral vectors, cells were incubated with 20-μl 5 mg/ml MTT (MP Biomedicals, USA) for 4 h. The precipitates were extracted with 180-μl DMSO and the absorbance was measured at the optical density (OD) of 490 nm as the viability index. Cell death was determined by PI staining, as previously reported 25 , 26 , according to manufacturer’s instruction (Sigma-Aldrich, USA).…”

“…Total RNA was collected from cells or retinal tissues by direct adding Trizol Reagent (Takara, Japan) and was purified by phenol-chloroform extraction. cDNA synthesis and PCR procedures were performed as described 25 , 26 . The primer sequences of the genes detected in this study were listed in the Supplementary Table 1 .…”